Search by Drug Name or NDC
NDC 57896-0181-05 Artificial Tears .002; .002; .01 mg/mg; mg/mg; mg/mg Details
Artificial Tears .002; .002; .01 mg/mg; mg/mg; mg/mg
Artificial Tears is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Geri-Care Pharmaceuticals, Corp. The primary component is GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400.
Product Information
| NDC | 57896-0181 |
|---|---|
| Product ID | 57896-181_08f3abb6-28fc-cc3d-e063-6394a90accee |
| Associated GPIs | 86209903302020 |
| GCN Sequence Number | 043044 |
| GCN Sequence Number Description | peg 400/hypromellose/glycerin DROPS 1-0.2-0.2% OPHTHALMIC |
| HIC3 | Q6T |
| HIC3 Description | ARTIFICIAL TEARS |
| GCN | 92824 |
| HICL Sequence Number | 020361 |
| HICL Sequence Number Description | POLYETHYLENE GLYCOL 400/HYPROMELLOSE/GLYCERIN |
| Brand/Generic | Generic |
| Proprietary Name | Artificial Tears |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Glycerin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | .002; .002; .01 |
| Active Ingredient Units | mg/mg; mg/mg; mg/mg |
| Substance Name | GLYCERIN; HYPROMELLOSES; POLYETHYLENE GLYCOL 400 |
| Labeler Name | Geri-Care Pharmaceuticals, Corp |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M018 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 57896-0181-05 (57896018105)
| NDC Package Code | 57896-181-05 |
|---|---|
| Billing NDC | 57896018105 |
| Package | 1 BOTTLE in 1 CARTON (57896-181-05) / 15 mg in 1 BOTTLE |
| Marketing Start Date | 2018-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |